Methylation of the hDAB2IP Gene in Gastrointestinal Tumors
Author Information
Author(s): Dote H, Toyooka S, Tsukuda K, Yano M, Ota T, Murakami M, Naito M, Toyota M, Gazdar A F, Shimizu N
Primary Institution: Okayama University Graduate School of Medicine and Dentistry
Hypothesis
The study investigates the methylation and expression status of the hDAB2IP gene in gastrointestinal tumors.
Conclusion
The study found that hDAB2IP methylation is frequently present in gastrointestinal tumors and contributes to gene silencing, which plays a significant role in carcinogenesis.
Supporting Evidence
- 67% of gastric cancer cell lines showed aberrant methylation in the hDAB2IP gene.
- 46% of primary gastric cancer tissues exhibited methylation in the m2a region.
- 48% of colorectal cancer tissues showed methylation in the m2b region.
- 12% of gastrointestinal nonmalignant mucosal specimens showed methylation in the m2a region.
- 5-aza-2'-deoxycytidine treatment restored gene expression in methylated cell lines.
Takeaway
The study shows that a specific gene, hDAB2IP, gets turned off in stomach and colon cancers due to a process called methylation, which can lead to cancer development.
Methodology
The study used bisulphite DNA sequencing and methylation-specific PCR to analyze the methylation status of the hDAB2IP gene in gastric and colorectal cancer samples.
Limitations
The study had a limited number of cell lines and may not represent all gastrointestinal tumors.
Participant Demographics
The study included patients with primary gastric and colorectal cancers, with a mix of male and female participants.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website